e-learning
resources
Barcelona 2013
Tuesday, 10.09.2013
Bacterial, fungal and mycobacterial infections
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
No difference in moxifloxacin penetration between infected and uninfected pleural fluid
K. Chatzika, K. Manika, P. Kontou, G. Pitsiou, K. Zarogoulidis, I. Kioumis (Thessaloniki, Greece)
Source:
Annual Congress 2013 –Bacterial, fungal and mycobacterial infections
Session:
Bacterial, fungal and mycobacterial infections
Session type:
Thematic Poster Session
Number:
4374
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. Chatzika, K. Manika, P. Kontou, G. Pitsiou, K. Zarogoulidis, I. Kioumis (Thessaloniki, Greece). No difference in moxifloxacin penetration between infected and uninfected pleural fluid. Eur Respir J 2013; 42: Suppl. 57, 4374
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Improvement in culture yield using blood culture bottles in infected pleural fluid
Source: International Congress 2015 – Clinical issues in CAP: microbiological and radiological determinants
Year: 2015
Penetration of azithromycin in experimental pleural empyema model fluid
Source: Annual Congress 2007 - Community-acquired pneumonia: from aetiology to complication
Year: 2007
The infected pleural space
Source: Annual Congress 2008 - The thoracic surgeon facing infection
Year: 2008
Penetration of linezolide in experimental pleural empyema model fluid
Source: Annual Congress 2007 - Community-acquired pneumonia: from aetiology to complication
Year: 2007
Intrapleural tPA increases pleural fluid output in pleural infection, independent of chest X-ray opacification
Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management
Year: 2015
Management of pleural infection
Source: Short video discussion 2021
Year: 2021
Antibiotics for pleural infections
Source: Eur Respir Monogr 2017; 75: 253-263
Year: 2017
Infectious pleural effusions
Source: ISSN=1025-448x, ISBN=1-904097-25-1, page=204
Year: 2002
Pleural infection
Source: International Congress 2017 – PG5 Pleural disease management
Year: 2017
Pharmacokinetics and pharmacoynamics of clarithromycin in the empyema pleural fluid
Source: Eur Respir J 2004; 24: Suppl. 48, 637s
Year: 2004
Immune responses in lungs of patients with tuberculous pleural effusion without pulmonary tuberculosis
Source: Annual Congress 2013 –Tuberculosis: clinical aspects
Year: 2013
Treatment of parapneumonic pleural effusion and empyema by chest drainage with a thin slit-type catheter
Source: International Congress 2014 – Different interesting issues in respiratory infections: 1
Year: 2014
Prevention of pleural infection
Source: International Congress 2019 – Respiratory infections: prevention is better than cure
Year: 2019
The changing pathogens in pleural infections
Source: ISSN=ISSN 1810-6838, ISBN=, page=162
Year: 2007
Pleural effusion cytokine profiles in HIV/MTB co-infection
Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: diagnostic tools
Year: 2012
Usefulness of BAL in non-HIV inmunocompromised hosts with lung infiltrates
Source: International Congress 2014 – Resistance, bacteriological profile and comorbidities in respiratory infections
Year: 2014
Is empirical antibiotic treatment correlated to outcome in microbiology-negative pleural infection?
Source: International Congress 2016 – Severe respiratory infections in the intensive care unit and pleural and fungal infections
Year: 2016
Pulmonary nocardiosis-always an opportunist infection?
Source: Annual Congress 2013 –Bacterial, fungal and mycobacterial infections
Year: 2013
Pleural infection and empyema
Source: Annual Congress 2012 - PG16 ERS/ACCP joint course on diagnostic and management strategies for pleural disorders
Year: 2012
High fluorescence cells in pleural fluid. Association with pleural malignancy
Source: Annual Congress 2013 –Clinical problems in mediastinal and pleural malignacies
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept